% Expired Patents = 80.0

Forward Citations = 217

Loading Chart...

3 inventors (with patents filed for the assignee):

Eugene deJuan (4 out of 6 patents)

Paul Hallen (4 out of 5 patents)

Mark Salman Humayun (1 out of 202 patents)

5 patents: Sort by Forward Citations

1. 7276019 - Ophthalmic treatment apparatus (2007-10-02),

2. 7223225 - Intraocular radiotherapy treatment for macular degeneration (2007-05-29),

3. 7220225 - Intraocular radiotherapy treatment (2007-05-22),

4. 6875165 - Method of radiation delivery to the eye (2005-04-05),

5. 6800076 - Soft tip cannula and methods for use thereof (2004-10-05),

Company Overview

Retinalabs, Inc. is a cutting-edge technology company specializing in developing innovative solutions for retinal imaging and analysis. Our products range from advanced imaging devices to software applications that aid in the early detection and treatment of retinal diseases. With a team of dedicated professionals and experts in the field, we are committed to improving the lives of patients and advancing the field of ophthalmology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#350 in Atlanta, GA

#993 in Georgia

#51,620 in US

Atlanta, GA, United States of America

Retinalabs, Inc.

Forward Citations = 217

3 inventors:

Eugene deJuan (4 out of 6 patents)

Paul Hallen (4 out of 5 patents)

Mark Salman Humayun (1 out of 202 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Retinalabs, Inc.. Retrieved from https://idiyas.com/company/retinalabs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]